Rebamipide - ≥98%, high purity , CAS No.90098-04-7, Agonist of CCK 1 receptor

Item Number

R129303

• Synonyms: 2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid | s2032 | (+-)-2-(4-Chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid | CAS-90098-04-7 | N-[(4-chlorophenyl)carbonyl]-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine | NCGC00095161-03 | SR-
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: Rebamipide enhances mucosal resistance, increases prostaglandin in gastric mucosa, and also scavenges oxygen-derived free radicals and inhibits their production.Derivative of 2-(1 H )-quinolinone with multiple biological activities. Stimulates prostagland
• Shipped In: Normal
• Grade: Moligand™
• Action Type: AGONIST
• Mechanism of action: Agonist of CCK 1 receptor
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Rebamipide is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.
An inducer of endogenous prostaglandin and a oxygen-derived free radical scavenger.

product description：

Rebamipide is a mucoprotective agent. Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner；